Company Filing History:
Years Active: 2017
Title: Anil Suri: Innovator in Anticancer Research
Introduction
Anil Suri is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of cancer research, particularly through his innovative work on anticancer agents. His dedication to developing effective treatments for cancer has positioned him as a key figure in the pharmaceutical industry.
Latest Patents
Anil Suri holds a patent for an anticancer agent. This invention provides microbial products as anticancer agents and pharmaceutical compositions comprising isolated and purified proteins or synthetic peptides. The methods outlined in his patent focus on using these agents for the treatment of cancer. His work emphasizes the importance of developing new anticancer bioactive peptides that exhibit high activity and low toxicity, addressing the limitations of current therapies that often have significant side effects or lead to resistance.
Career Highlights
Anil Suri is associated with Amrita Therapeutics Limited, where he continues to advance his research in cancer treatment. His career is marked by a commitment to innovation and a focus on improving patient outcomes through scientific discovery.
Collaborations
Anil collaborates with talented professionals in his field, including Deepika Kanojia and Prabhakar Salunkhe. Their combined expertise contributes to the ongoing development of effective cancer therapies.
Conclusion
Anil Suri's work in the field of anticancer research exemplifies the impact of innovation on healthcare. His patent for an anticancer agent highlights the potential for new treatments that can improve the lives of cancer patients.